Skip to main content
SpringerLink
Log in

In a precautionary move, ratiopharm is initiating a voluntary recall of a number of lots of controlled-release morphine tablets in Canada

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Health Canada.Health Canada Endorsed Important Safety Information on ratio-Morphine SR 15 mg, 30 mg and 60 mg tablets. Media Release: 8 Jul 2008. Available from: URL: http://www.hc-sc.gc.ca

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

In a precautionary move, ratiopharm is initiating a voluntary recall of a number of lots of controlled-release morphine tablets in Canada. React. Wkly. 1212, 3 (2008). https://doi.org/10.2165/00128415-200812120-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812120-00010

Keywords

Search

Navigation